![Mahesh Karande](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mahesh Karande
Direktor/Vorstandsmitglied bei
KSQ Therapeutics, Inc.
Profil
Mahesh Karande is currently a Director at Ashvattha Therapeutics Inc since 2023 and a Director at KSQ Therapeutics, Inc. since 2022.
Previously, he held the position of President & Chief Executive Officer at Zikani Therapeutics, Inc. from 2018 to 2019, President, Chief Executive Officer & Director at Omega Therapeutics, Inc. from 2019 to 2024, Vice President & Head-US Oncology at Novartis, Inc. from 2010 to 2017, President at Novartis SA from 2010 to 2017, and President at Novartis Pharma SAE from 2010 to 2017.
Mr. Karande has a graduate degree from Georgia Institute of Technology, an undergraduate degree from the University of Mumbai, and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Mahesh Karande
| Unternehmen | Position | Beginn |
|---|---|---|
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Direktor/Vorstandsmitglied | 08.12.2022 |
Ashvattha Therapeutics Inc
 Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 31.05.2023 |
Ehemalige bekannte Positionen von Mahesh Karande
| Unternehmen | Position | Ende |
|---|---|---|
| OMEA THER | Vorstandsvorsitzender | 14.11.2024 |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Vorstandsvorsitzender | 01.03.2019 |
Novartis Pharma SAE
 Novartis Pharma SAE Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Präsident | 01.04.2017 |
Novartis SA
 Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Präsident | 01.04.2017 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 01.04.2017 |
Ausbildung von Mahesh Karande
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis SA
Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Health Technology |
Novartis Pharma SAE
Novartis Pharma SAE Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ashvattha Therapeutics Inc
Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Wählen Sie MarketScreener 
